share_log

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Lowers Price Target to $15

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Lowers Price Target to $15

坎托·菲茨杰拉德维持对Cresco Labs的增持,将目标股价下调至15美元
Benzinga Real-time News ·  2022/08/18 05:30

Cantor Fitzgerald analyst Pablo Zuanic maintains Cresco Labs (OTC:CRLBF) with a Overweight and lowers the price target from $19 to $15.

坎托·菲茨杰拉德分析师巴勃罗·祖安尼奇维持Cresco Labs(场外交易代码:CRLBF)增持 “增持”,并将目标股价从19美元下调至15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发